🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT07049289
Active, not recruiting Not applicable

Telemonitoring in Arterial Hypertension

NCT07049289 · tracked via the Priya Life Science Germany tracker
Phase
Not applicable
Started
2023-12-13
Last updated
2025-07-03

Condition(s) studied

Arterial HypertensionUncontrolled Hypertension

Investigational drug(s) / intervention(s)

Telemonitoring

Telemonitoring: Patients randomized to intervention group will receive biweeky telephone calls and adaption of antiyhpertensive medication if needed

Study summary

Prospective, randomized trial to assess the effects of a telemedical approach of antihypertensive treatment in comparison with standard care.

Total patient number: 60 patients.

* Intervention group: biweekly telephone calls
* Control group: standard of care

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. Confirmed arterial hypertension with systolic or diastolic blood pressure \>140/90 mmHg in standardized office blood pressure measurement 2. Treatment with 1 to ≤4 antihypertensive drug classes 3. Age \>18 years 4. Written informed consent Exclusion Criteria: 1. Pregnancy 2. Participation in other randomized trials 3. Patients under legal supervision or guardianship

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Heart Centre Leipzig Leipzig Germany

More Heart Center Leipzig - University Hospital trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07049289 on ClinicalTrials.gov ↗ ← All trials in Germany